July 24, 2021

The World Stock Markets Tips & Targets, News, Views & Updates

The World Stock Markets Tips & Targets, News, Views & Updates

Divi’s Labs won big in a low-value segment with a curated portfolio. Will its dream run sustain?

Dr. Murali K. Divi, managing director, Divi’s Laboratories Ltd.; Image courtesy: divislabs.com

Synopsis

The strong performance of Murali Divi’s company is a result of choosing the right products, securing scale, forging global partnerships, and keeping an unwavering eye on costs. Besides, in an industry with stringent quality standards, it has a clean report card. But will it be able to keep the ball rolling?

Drug maker Divi’s Laboratories has come to acquire a distinct edge that its peers envy. It has won the trust of customers and guarded itself relatively better against headwinds. Investors continue to believe in Divi’s, a deep bond they have shared since its listing in 2003. For months now, Divi’s has been sitting firmly atop the market capitalisation in its industry group, second only to Sun Pharmaceutical Industries. On July 20, Divi’s market

Share This Article

  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • PRINT
  • COMMENT

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Mega Monsoon Offer on ET Prime

Celebrate the rains with ET Prime. Get 30% Off on 1 & 2 Year Plans

Get Offer

Mega Monsoon Offer on ET Prime

Subscribe to ET Prime – Get Flat 30% Off

Get Offer

Mega Monsoon Sale

Subscribe to ET Prime – Get Flat 30% Off

Get Offer

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

Share This :